|
Early Hearing Detection and Intervention
|
Meeting/ Workshop
|
CDC
|
NIDCD
|
This collaboration focuses on a teleconference sponsored by CDC.
|
|
Early Learning Interagency Policy Board (IPB)
|
Other
|
ACF
|
NICHD, NIDA
|
The purpose of this workgroup is to collaborate with the Administration for Children and Families (ACF) in order to coordinate efforts in the area of preschool education, including research.
|
|
Ebola Clinical Research Response in West Africa
|
Research Initiative
|
CDC, FDA
|
NIAID
|
Research collaborations to respond to Ebola emergency in West Africa
|
|
Electronic Health Record Pediatric Practice Based Research Network (PBRN)
|
Research Initiative
|
HRSA
|
NICHD
|
This Interdepartmental Delegation Authority (IDDA) (NIH-13-030) funds the following activities: Electronic Health Record (EHR) Pediatric Practice Based Research Network (PBRN) Initiative; and Comparative Effectiveness Research (CER) and epidemiologic assessments of the use of selected psychotropic medications and the most commonly prescribed asthma medications in pediatric populations.
|
|
Electronic Research Administration (eRA)
|
Other
|
AHRQ, CDC, FDA, SAMHSA
|
NINR, CSR, FIC, NCATS, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NLM, OD/OER
|
The Electronic Research Administration (eRA) provides information technology solutions and support for the full life cycle of grants administration functions for the NIH as well as the Agency for Healthcare Research and Quality (AHRQ), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), and the Veterans Health Administration (VHA). eRA offers vital solutions to manage the receipt, processing, review, award and monitoring of over $30 billion in research and nonresearch grants awarded annually by NIH and other grantor agencies in support of the collective mission of improving human health. eRA helps NIH meet a vital mission: the support of cutting edge biomedical research via grants to scientists at universities and other research institutions. Over 4,100 NIH staff, 729 partner agency staff, and 171,083 active external users depend on eRA daily. Used by Federal staff and applicants at over 28,400 research institutions worldwide, eRA has helped eliminate the hundreds of millions of pieces of paper previously required to: • Record, review and process over 89,600 applications each year. • Support more than 3,960 review meetings held annually. • Administer more than 61,200 awarded competing and noncompeting grants. • Maintain patent and invention records for 32 Federal agencies (see the iEdison website). • Support thousands of applicant interactions with the Federal Government before and after the grant award, through the eRA online interface. eRA''s focus is on supporting the mission of serviced agencies by providing tools to electronically manage and report on grants in a way that maximizes efficiencies, provides a strong and scalable infrastructure, is responsive to evolving customer needs and employs sound management controls. eRA systems align with Grants.gov (the one stop web portal for finding and applying for federal grants), allowing for full electronic processing of grant applications from application submission through closeout of the grant award and reporting thereafter. eRA operates as a fee for service activity to OPDivs and other federal agencies.
|
|
Emergency Care Research Interagency Program Officer Working Group
|
Committee, Work group, Advisory group, or Task Force
|
HRSA
|
NICHD, NHLBI, NINDS
|
This working group aims to share common challenges in conducting emergency care research, identify innovative solutions amongst the projects in NIH Institutes/Centers portfolios for common problems; discuss performance evaluation of emergency care networks; and discuss models for funding and evaluating data coordinating centers. (Ad hoc)
|
|
Emergency Preparedness, Medical Countermeasures
|
Resource Development
|
OS
|
NCI
|
NCI provides expertise in radiation biology and radiation oncology to help guide the research and development for medical countermeasures for radiation injury and for biomarkers for assessing injury, dose and who needs treatment.
|
|
Endocrinologic and Metabolic Drugs Advisory Committee
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIAID
|
This Committee provides expertise in the evaluation of evidence submitted by pharmaceutical companies to the FDA for drug approval.
|
|
Enhancing the National Death Index (NDI)
|
Resource Development
|
CDC
|
NIA, NCI, NHLBI
|
This agreement will enable the Centers for Disease Control and Prevention (CDC) National Center for Health Statistics to expedite the processing of state death certificate data for annual updates to the National Death Index (NDI).
|
|
Ethical, Legal and Social Issues (ELSI) Sub-study in the Biospecimen Pre-Analytical Variables (BPV) Project
|
Research Initiative
|
OS
|
NCI, CC
|
This Substudy is part of ongoing efforts by the Cancer Human Biobank (caHUB) program to improve effectiveness and generate best practices for the biospecimen research community. The Biospecimen Pre-Analytical Variables (BPV) Ethical Legal and Social Implications (ELSI) Substudy is a study of the ethical, legal and social implications related to the informed consent process for biobanking. The ELSI study is designed to address current issues related to informed consent for biobanking, particularly the issues of consent for broad future research use and return of research results. The objective of the ELSI Substudy is to assess research participant comprehension and concerns related to informed consent and data sharing for biobanking across the diverse patient populations included in the BPV program. The intent of this evaluation is to improve our understanding of the issues that impact donor participation in such programs and to identify factors that may result in decreased rates of donor participation. This study provides a unique and unprecedented opportunity to address these issues in a diverse patient population of actual biospecimen contributors approached for consent using a highly harmonized informed consent document. Each Biospecimen Source Site (BSS) collecting tumor tissue from surgical procedures is participating in the ELSI study. To date, 247 interviews with BPV participants have been submitted for analysis. Data collection will conclude in May of 2015 and data analysis will begin at that point.
|